Page last updated: 2024-08-23

dihydroxyethyldithiocarbamate and erythrosine

dihydroxyethyldithiocarbamate has been researched along with erythrosine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rieber, M; Rieber, MS; Viola-Rhenals, M1

Other Studies

1 other study(ies) available for dihydroxyethyldithiocarbamate and erythrosine

ArticleYear
Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
    Biochemical pharmacology, 2006, Mar-14, Volume: 71, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; Ditiocarb; Fluoresceins; Humans; Hydroxyquinolines; Organometallic Compounds; Oxyquinoline; Zinc

2006